GENE ONLINE|News &
Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition
After establishing its footprint in the west, Durham-based BioAgilytix Labs is looking to broaden its presence on the other side of the world. On August 16th, the leading global contract research laboratory announced plans to buy Australian CRO 360biolabs for an undisclosed amount.
BioAgilytix is currently operating in two US locations; Durham, North Carolina, and Boston, Massachusetts. Besides, it also has a laboratory in Hamburg, Germany. With the latest acquisition of 360biolabs, the company aims to extend its services to customers in Melbourne, Victoria.
BioAgilytix is currently operating in two US locations; Durham, North Carolina, and Boston, Massachusetts. Besides, it also has a laboratory in Hamburg, Germany. With the latest acquisition of 360biolabs, the company aims to extend its services to customers in Melbourne, Victoria.
GO Prime with only $1.49 now
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
